Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future

MA Davidson, DR Mattison, L Azoulay… - Critical reviews in …, 2018 - Taylor & Francis
Thiazolidinedione (TZD) drugs used in the treatment of type 2 diabetes mellitus (T2DM)
have proven effective in improving insulin sensitivity, hyperglycemia, and lipid metabolism …

[图书][B] Pediatric endocrinology: growth, adrenal, sexual, thyroid, calcium, and fluid balance disorders

F Lifshitz - 2006 - books.google.com
Celebrating more than twenty years as the single best source in the field, this Fifth Edition
has now expanded into two cornerstone volumes with 53 fully inclusive chapters and 73 …

Growth hormone excess: Implications and management

S Dhaneshwar, S Shandily… - Endocrine, Metabolic & …, 2023 - ingentaconnect.com
Acromegaly is described as the oversecretion of growth hormone (GH) and, subsequently,
insulin-like growth factor 1 (IGF-1), ascribed in most cases to a pituitary adenoma. This …

Efficacy and safety of CyberKnife radiosurgery for acromegaly

BK Roberts, DL Ouyang, SP Lad, SD Chang, GR Harsh… - Pituitary, 2007 - Springer
Objective Acromegaly is a disease characterized by GH hypersecretion, and is typically
caused by a pituitary somatotroph adenoma. The primary mode of therapy is surgery, and …

Substantial shrinkage of adenomas cosecreting growth hormone and prolactin with use of cabergoline therapy

L Vilar, MA Czepielewsk, LA Naves, GAFS Rollin… - Endocrine Practice, 2007 - Elsevier
Objective To present 2 cases of patients with acromegaly and severe hyperprolactinemia
whose primary therapy with cabergoline resulted in hormonal normalization and a …

Overgrowth disorders associated with tall stature

JF Sotos, J Argente - Advances in pediatrics, 2008 - advancesinpediatrics.com
In the context of this review, a number of disorders of overgrowth characterized by tall
stature, defined as a height of more than 2 standard deviations (2 SD) or excessive growth …

[PDF][PDF] Musculo-skeletal stress markers in bioarchaeology: indicators of activity levels or human variation? A re-analysis and interpretation.

C Henderson - 2009 - etheses.dur.ac.uk
Durham E-Theses Page 1 Durham E-Theses Musculo-Skeletal Stress Markers in
Bioarchaeology: Indicators of Activity Levels or Human Variation? A re-analysis and …

Clinical features and therapeutic outcomes of acromegaly during the recent 10 years in a single institution in Japan

I Fukuda, N Hizuka, T Muraoka, M Kurimoto… - Pituitary, 2014 - Springer
Untreated acromegaly is associated with a twofold to fourfold increased mortality risk
compared to the population. Recently, new therapeutic modalities have been developed …

[HTML][HTML] Has acromegaly been diagnosed earlier?

H Ohno, Y Yoneoka, S Jinguji, N Watanabe… - Journal of Clinical …, 2018 - Elsevier
Purpose We investigated whether acromegaly has been diagnosed earlier at the Niigata
Medical and Dental University Hospital. Methods Patients with acromegaly (n= 81) who …

Drug insight: primary medical therapy of acromegaly

L Katznelson - Nature Clinical Practice Endocrinology & Metabolism, 2006 - nature.com
Acromegaly is an insidious disease that, in most cases, is a result of a pituitary adenoma that
hypersecretes growth hormone (GH). The goals of therapy are to control excess GH …